Dr. Stephen Robbins
March 2021Research at the Lady Davis Institute

A year with COVID-19: The therapeutic pipeline

Dr. Stephen Robbins, new Director of the Lady Davis Institute, and Dr. Donna Senger, of the LDI’s Cancer Axis, have received up to $6.7 million in federal support for a drug candidate that could bring relief to hospitalized patients with a severe case of COVID-19.

READ MORE →
Illustration from the home page of the new website of the Centre of Excellence in Thrombosis and Anticoagulation Care.
February 2021Health tips

Need info on deep vein thrombosis and pulmonary embolisms? A new JGH website can help

Looking for information about blood clots, deep vein thrombosis and pulmonary embolisms? A new JGH website has the information you need.

READ MORE →
Dr. Brent Richards
November 2017Research at the Lady Davis Institute

Largest genetic study identifies potential targets for osteoporosis

The largest study ever conducted on the genetics of common, age-related bone disease has resulted in the identification of 153 new gene variants associated with the loss of bone mineral density, the strongest clinical risk factor for osteoporosis and a frequent cause of fractures.

READ MORE →
Dr. Samy Suissa
October 2016Research at the Lady Davis Institute

Mandate renewed for Canada-wide drug safety consortium based at the LDI

A renewed five-year mandate has been granted to a national consortium on prescription drug safety that is headquartered in the Lady Davis Institute at the JGH.

READ MORE →
Dr. Samy Suissa
Research at the Lady Davis InstituteSpring 2015

Link found between pain reliever
and hypoglycemia

Tramadol, a weak opioid for treating moderate to moderately severe pain, can be linked in some cases to an increased risk of hospitalization for hypoglycemia, concludes a study by a team of epidemiologists in the Lady Davis Institute at the JGH.

READ MORE →
Dr. Samy Suissa
Fall 2014Research at the Lady Davis Institute

Weekend deaths more likely for certain hospitalized patients

People with chronic obstructive pulmonary disease (COPD) or pneumonia are more likely to die during a weekend stay in hospital, concludes a study conducted by Dr. Samy Suissa, Director of the Centre for Clinical Epidemiology in the Lady Davis Institute at the JGH.

READ MORE →
Dr. Mark Eisenberg and research assistant Carolyn Franck have collaborated on a systematic review of existing research into the safety and effectiveness of electronic cigarettes.
Fall 2014Research at the Lady Davis Institute

Can e-cigarettes help smokers butt out?

Dr. Mark Eisenberg, a researcher at the Centre for Clinical Epidemiology in the Lady Davis Institute at the JGH, has received more than $800,000 to lead a randomized clinical trial to determine whether electronic cigarettes can help smokers kick the habit.

READ MORE →